2. Balmelli C.,
Demotz S., Acha-Orbea H., De Grandi P., and Nardelli-Haefliger D. (2001).
Interaction of human papillomavirus type 16 (HPV16) virus-like particles
(VLP) with professional antigen presenting cells. Annual assembly of SSM,
Lausanne; oral presentation
3. Balmelli C., Demotz S.,
Acha-Orbea H., De Grandi P., and Nardelli-Haefliger D. (2000). Presentation
of human papillomavirus type 16(HPV16) virus-like particles (VLPs) by professionnal
antigen presenting cells (APC) following vaccination of mice with HPV16
VLPs. Annual meeting of the swiss society for oncology, Switzerland. Abstract.
4. Balmelli C., Demotz S.,
Acha-Orbea H., De Grandi P., and Nardelli-Haefliger D. (2000). Detection
of L1-antigen-presenting cells following vaccination of mice with
Human Papillomavirus type 16 (HPV16) virus-like-particles (VLPs). 18th
International Papillomavirus Conference, Barcelona, Spain. Abstract.
5. Balmelli C., Demotz S.,
Acha-Orbea H., De Grandi P., and Nardelli-Haefliger D. (2000). Presentation
of Human Papillomavirus type 16 (HPV16) Virus-Like-Particles (VLP) by professional
Antigen Presenting Cells (APC). Meeting of the swiss immunology Ph.D. Students,
Schloss Wolfsberg, Switzerland, Abstract
6. Balmelli C., Demotz S.,
Acha-Orbea H., De Grandi P., and Nardelli-Haefliger D. (2000). In vitro
and in vivo presentation of Human papillomavirus (HPV) Type 16 Virus-Like-
Particles by professional Antigen Presenting Cells (APC). Congress of the
Swiss Society for Allergology and Immunology 2000, Abstract.
7. Balmelli C., Demotz S.,
Acha-Orbea H., De Grandi P. and Nardelli-Haefliger D. (1999). In vitro
and In vivo Presentation of Human Papillomavirus (HPV) Type 16 Virus-Like
Particles (VLP). 31th Annual meeting of the USGEB/USSBE, Abstract.
8. Balmelli C., Demotz S.,
P.De Grandi and Nardelli-Haefliger D. (1999). Detection of specific antigen
presenting cells in mice after intranasal immunization with Human Papillomavirus
type 16 virus-like-particles. 10th International Congress of Mucosal Immunology,
Amsterdam, The Netherland, Immunology letters, in press.
9. Nardelli-Haefliger D.,
Roden R., Potts A., Balmelli C., Schiller J. and De Grandi P. (1999). Only
Mucosal Immunization with Human Papillomavirus type 16 (HPV16) Virus-Like.Particles
(VLP) Elicits a Continuous Induction of HPV16 Neutralizing Antibodies Along
the Estrous Cycle of Mice.17th International Papillomavirus Conference,
Charleston, North Carolina, USA, Abstract.
10. Balmelli C., Demotz S.,
De Grandi P. and Nardelli-Haefliger D.(1999). Detection of Specific Antigen
Presenting Cells in Mice after Intranasal Immunization with Human Papillomavirus
Type 16 Virus-Like-Particles. Metting of the swiss immunology Ph.D. Students,
Schloss Wolfsberg, Switzerland, Abstract
11. Balmelli C., (1998).Mucosal
Protocols of Immunization for Induction of Neutralizing Human Antibodies
in Genital Secretions of Mice. 30th Annual meeting of the USGEB/USSBE,
Abstract.
12. Balmelli C., Potts A.,
Schiller J., De Grandi P. and Nardelli-Haefliger D.(1997). Nasal Immunization
with Human Papillomavirus type 16 Virus-like particles Elicits L1-Specific
antibodies in serum and genital secretions of mice.16th International Papillomavirus
Conference, Siena, Italy, Abstract.
13. Balmelli C., Potts A.,
Schiller J., De Grandi P. and Nardelli-Haefliger D.(1997). Nasal Immunization
with Human Papillomavirus type 16 Virus-like particles Elicits L1-Specific
antibodies in serum and genital secretions of mice. 29th Annual meeting
of the USGEB/USSBE, Abstract
